INSUFICIÊNCIA CARDÍACA DESCOMPENSADA EM NONAGENÁRIOS
PERFIL CLÍNICO E TERAPÊUTICO
Palavras-chave:
Nonagenários, Insuficiência cardíaca., Tratamento farmacológico.Resumo
Objetivo: analisar o perfil clínico e terapêutico da chegada à emergência, do internamento e da alta entre nonagenários internados com insuficiência cardíaca descompensada. Métodos: estudo observacional, retrospectivo, com uma amostra de 45 pacientes internados com diagnóstico de insuficiência cardíaca descompensada, entre 04/2007 e 06/2018, em um hospital da rede suplementar de saúde da cidade do Recife/PE, na população de pacientes com idade maior ou igual a 90 anos. Resultados: a amostra consistiu em 45 pacientes, com média de idade de 93 anos, sendo a hipertensão arterial sistêmica (91,1%) e a doença arterial coronariana (77,7%) as comorbidades mais prevalentes. A etiologia mais comum foi a miocardiopatia isquêmica (43,2%). Infecções foram a principal causa de descompensação (56,8%). A taxa de mortalidade intra-hospitalar foi de 24% e a de reinternação foi de 27%. Conclusão: o tratamento da ICD em nonagenários deve ser adaptado para atender as necessidades específicas dessa faixa etária, com foco na prevenção de infecções e na otimização das terapias farmacológicas, visando reduzir as taxas de mortalidade e reinternação.
Downloads
Referências
Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail [Internet]. 2021 Mar [cited 2025 Apr 27];23(3):352-80. Available from: https://doi.org/10.1002/ejhf.2115
Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail [Internet]. 2013 May [cited 2025 Apr 27];6(3):606-19. Available from: https://doi.org/10.1161/hhf.0b013e318291329a
American Heart Association. Heart Disease and Stroke Statistical update [Internet]. Dallas: AHA; 2022 [cited 2025 Apr 27]. Available from: http://www.americanheart.org/statistics
Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation [Internet]. 2012 Jul [cited 2025 Apr 27];126(1):65–75. Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.080770
Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci [Internet]. 2012 Apr [cited 2025 Apr 27];67(4):395-405. Available from: https://doi.org/10.1093/gerona/glr223
Pachana NA. Encyclopedia of geropsychology. New York: Springer; 2016.
National Heart, Lung, and Blood Institute. Prevalence of heart failure among US adults ≥20 years of age by sex and age (NHANES, 2015-2018) [Internet]. Bethesda (MD): NHLBI; 2018 [cited 2025 Apr 27]. Available from: https://www.nhlbi.nih.gov/
Centers for Disease Control and Prevention. NHANES Questionnaires, Datasets, and Related Documentation [Internet]. Atlanta: CDC; 2020 [cited 2025 Apr 27]. Available from: https://www.cdc.gov/nchs/nhanes
Von Berenberg P, Drager D, Zahn T, Neuwirth J, Kuhlmey A, Gellert P. Chronic conditions and use of health care service among German centenarians. Age Ageing [Internet]. 2017 Nov [cited 2025 Apr 27];46(6):939-45. Available from: https://doi.org/10.1093/ageing/afx008
Huffman MD, Berry JD, Ning H, Dyer AR, Garside DB, Cai X, et al. Lifetime risk for heart failure among White and Black Americans: cardiovascular lifetime risk pooling project. J Am Coll Cardiol [Internet]. 2013 Apr [cited 2025 Apr 27];61(14):1510-7. Available from: https://doi.org/10.1016/j.jacc.2013.01.022
Folsom AR, Shah AM, Lutsey PL, Roetker NS, Alonso A, Avery CL, et al. American Heart Association’s Life’s Simple 7: avoiding heart failure and preserving cardiac structure and function. Am J Med [Internet]. 2015 Sep [cited 2025 Apr 27];128(9):970-6. Available from: https://doi.org/10.1016/j.amjmed.2015.03.027
Butler J, Yang M, Manzi MA, Hess GP, Patel MJ, Rhodes T, et al. Clinical course of patients with worsening heart failure with reduced ejection fraction. J Am Coll Cardiol [Internet]. 2019 Mar [cited 2025 Apr 27];73(8):935-44. Available from: https://doi.org/10.1016/j.jacc.2018.11.049
Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Martha J, et al. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med [Internet]. 1997 Oct [cited 2025 Apr 27];157(19):2242-7. Available from: https://pubmed.ncbi.nlm.nih.gov/9343001/
Böhm M, Tschöpe C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, et al. Treatment of heart failure in real-world clinical practice: findings from the REFLECT-HF registry in patients with NYHA class II symptoms and a reduced ejection fraction. Clin Cardiol [Internet]. 2015 Apr [cited 2025 Apr 27];38(4):200-7. Available from: https://doi.org/10.1002/clc.22375
Lee DS, Mamdani MM, Austin PC, Gong Y, Liu PP, Rouleau JL, et al. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med [Internet]. 2004 May [cited 2025 Apr 27];116(9):581-9. Available from: https://doi.org/10.1016/j.amjmed.2003.11.025
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J [Internet]. 2021 Sep [cited 2025 Apr 27];42(36):3599-726. Available from: https://doi.org/10.1093/eurheartj/ehab368
Huerta-Preciado J, Franco J, Formiga F, Llácer Iborra P, Epelde F, González Franco Á, et al. Differential characteristics of acute heart failure in very elderly patients: the prospective RICA study. Aging Clin Exp Res [Internet]. 2020 Sep [cited 2025 Apr 27];32(9):1789-99. Available from: https://doi.org/10.1007/s40520-019-01363-8
Rohde LEP, Danzmann LC, Canesin MF, Hoffmann Filho CR, Fragata Filho AA, Baruzzi A, et al. BREATHE-I Brazilian Registry of Heart Failure: rationale and design. Arq Bras Cardiol [Internet]. 2013 May [cited 2025 Apr 27];100(5):390-4. Available from: https://doi.org/10.5935/abc.20130093
Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J [Internet]. 2021 Feb [cited 2025 Apr 27];42(6):681-3. Available from: https://doi.org/10.1093/eurheartj/ehaa1012
Rosano GMC, Moura B, Metra M, Böhm M, Bauersachs J, Ben Gal T, et al. Patient profiling in heart failure for tailoring medical therapy: a consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail [Internet]. 2021 May [cited 2025 Apr 27];23(6):872-81. Available from: https://doi.org/10.1002/ejhf.2206
Shibata MC, Sonef CM, Tsuyuki RT. Utilization of evidence based therapies for heart failure in the institutionalized elderly. Eur J Heart Fail [Internet]. 2005 Dec [cited 2025 Apr 27];7(7):1122–5. Available from: https://doi.org/10.1016/j.ejheart.2005.03.005
Rich MW. Management of heart failure in the elderly. Heart Fail Rev [Internet]. 2002 Jan [cited 2025 Apr 27];7(1):89-97. Available from: https://doi.org/10.1023/a:1013706023974
Rich MW. Drug therapy of heart failure in the elderly. Am J Geriatr Cardiol [Internet]. 2003 Jul/Aug [cited 2025 Apr 27];12(4):235–42. Available from: https://doi.org/10.1111/j.1076-7460.2003.02013.x
O’Connell JB. The economic burden of heart failure. Clin Cardiol [Internet]. 2000 Mar [cited 2025 Apr 27];23(3 Suppl):6-10. Available from: https://doi.org/10.1002/clc.4960231503
Sargento L, Simões AV, Longo S, Lousada N, dos Reis RP. Treatment with optimal dose angiotensin-converting enzyme inhibitors/angiotensin receptor blockers has a positive effect on long-term survival in older individuals (aged >70 years) and octogenarians with systolic heart failure. Drugs Aging [Internet]. 2016 Sep [cited 2025 Apr 27];33(9):675-83. Available from: https://doi.org/10.1007/s40266-016-0393-y
